Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder

被引:0
作者
Kenji Hashimoto
机构
[1] Chiba University Center for Forensic Mental Health,Division of Clinical Neuroscience
来源
European Archives of Psychiatry and Clinical Neuroscience | 2016年 / 266卷
关键词
Schizophrenia; Bipolar Disorder; NMDA Receptor; Bipolar Disorder Patient; Serine Racemase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:83 / 85
页数:2
相关论文
共 127 条
[1]  
Maier W(2006)Schizophrenia and bipolar disorder: differences and overlaps Curr Opin Psychiatry 19 165-170
[2]  
Zobel A(2007)Increased levels of glutamate in brains from patients with mood disorders Biol Psychiatry 62 1310-1316
[3]  
Wagner M(2013)Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders Eur Arch Psychiatry Clin Neurosci 263 367-377
[4]  
Hashimoto K(2014)Targeting of NMDA receptors in new treatments for schizophrenia Expert Opin Ther Targets 18 1049-1063
[5]  
Sawa A(2003)Decreased serum levels of Arch Gen Psychiatry 60 572-576
[6]  
Iyo M(2005)-serine in patients with schizophrenia: evidence in support of the Biol Psychiatry 57 1493-1503
[7]  
Hashimoto K(2014)-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia Plos One 9 e101652-769
[8]  
Malchow B(2005)Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and Prog Neuropsychopharmacol Biol Psychiatry 29 767-51
[9]  
Falkai P(2007)-serine levels Schizophr Res 90 41-427
[10]  
Schmitt A(2014)Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients Nature 511 421-1665